INSTITUTE FOR CANCER RESEARCH H-1B Visa Sponsorship & Salary Data

The median H-1B salary at INSTITUTE FOR CANCER RESEARCH is $61,996, based on 79 certified filings from FY 2020 to FY 2025. This is 48% lower than the national H-1B median salary of $120,000. Compensation at INSTITUTE FOR CANCER RESEARCH reflects their market positioning, with entry-level roles starting around $55,307 and senior positions reaching $107,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at INSTITUTE FOR CANCER RESEARCH range from $53,269 at the 10th percentile to $107,000 at the 90th percentile, showing a $53,731 spread across experience levels and roles. The 25th percentile is $55,307 and the 75th percentile is $73,808.

Yes, INSTITUTE FOR CANCER RESEARCH actively sponsors H-1B visas in FY 2025. In the most recent fiscal year (FY 2025), INSTITUTE FOR CANCER RESEARCH filed 11 H-1B labor condition applications with 11 certified and 0 denied, at a median salary of $74,008. Across FY 2020–2025, they have filed 80 total H-1B applications with 79 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. INSTITUTE FOR CANCER RESEARCH sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), INSTITUTE FOR CANCER RESEARCH filed 11 H-1B applications, with 11 certified and 0 denied. Over 6 years of data, INSTITUTE FOR CANCER RESEARCH has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

INSTITUTE FOR CANCER RESEARCH's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 80 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating INSTITUTE FOR CANCER RESEARCH as a potential H-1B sponsor.

This is an excellent approval rate, indicating INSTITUTE FOR CANCER RESEARCH has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

INSTITUTE FOR CANCER RESEARCH sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 79 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles INSTITUTE FOR CANCER RESEARCH most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at INSTITUTE FOR CANCER RESEARCH:

The most frequently sponsored role is Associate Research Associate with 33 filings at a median salary of $60,780. This is followed by Scientific Associate (10 filings) and Assistant Professor.

INSTITUTE FOR CANCER RESEARCH's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where INSTITUTE FOR CANCER RESEARCH sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top INSTITUTE FOR CANCER RESEARCH H-1B locations:

The largest H-1B hub for INSTITUTE FOR CANCER RESEARCH is Philadelphia, PA with 79 filings at a median salary of $61,996.

INSTITUTE FOR CANCER RESEARCH's median H-1B salary has increased by +33% from FY 2020 ($55,614) to FY 2025 ($74,008). Tracking salary trends over time reveals how INSTITUTE FOR CANCER RESEARCH adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at INSTITUTE FOR CANCER RESEARCH.

Year-by-year breakdown:

• FY 2021: $55,307 (13 certified)
• FY 2022: $58,606 (15 certified)
• FY 2023: $61,996 (21 certified)
• FY 2024: $61,191 (7 certified)
• FY 2025: $74,008 (11 certified)

This 33% growth reflects strong compensation adjustments at INSTITUTE FOR CANCER RESEARCH, keeping pace with market demands for H-1B talent.

INSTITUTE FOR CANCER RESEARCH primarily files H-1B applications at Wage Level I, accounting for 85% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making INSTITUTE FOR CANCER RESEARCH's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

A significant portion of INSTITUTE FOR CANCER RESEARCH's H-1B filings are at entry-level (Level I) wages. These positions may face more competition in the H-1B lottery.

INSTITUTE FOR CANCER RESEARCH's median H-1B salary of $61,996 is 48% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating INSTITUTE FOR CANCER RESEARCH's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare INSTITUTE FOR CANCER RESEARCH's offerings with similar companies in your field for a more accurate assessment.

INSTITUTE FOR CANCER RESEARCH's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. INSTITUTE FOR CANCER RESEARCH files 85% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 79 certified filings, INSTITUTE FOR CANCER RESEARCH invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.